Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Evolus, Inc. (EOLS) will participate in the 23rd Annual Needham Virtual Healthcare Conference on April 9th, 2024. The management team will present at 9:30 AM ET, discussing the company's performance beauty focus. Investors can access the fireside chat on Evolus' Investor Relations page.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will present at the following investor conference in April:

Event: The 23^rd Annual Needham Virtual Healthcare Conference
Date: Tuesday, April 9^th, 2024
Time: 9:30 – 10:10 AM ET

The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available for 90 days following the presentation.

About Evolus, Inc.

Evolus (Nasdaq: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau^® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse™, and the exclusive distributor in Europe of Estyme^®, a line of unique dermal fillers currently in late-stage development. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.

Jeuveau^® and Nuceiva^® are registered trademarks of Evolus, Inc.
Evolysse^™ is a trademark of Evolus, Inc.
Hi-Pure^™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240326735225/en/

Investors:

Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications

Phone: (248) 202-9267

Email: ir@evolus.com

Media:

Email: media@evolus.com

Source: Evolus

FAQ

When is Evolus, Inc. (EOLS) participating in the 23rd Annual Needham Virtual Healthcare Conference?

Evolus will participate on Tuesday, April 9th, 2024.

At what time will the management team of Evolus present at the conference?

The presentation will be at 9:30 AM ET.

Where can investors access the fireside chat?

Investors can access it on Evolus' Investor Relations page.

Will there be a replay of the webcast available?

Yes, a replay will be available for 90 days after the presentation.